Futu News, April 27 | Hong Kong stocks opened lower and moved higher. The Hang Seng Index edged up 0.09% at noon, the HSCEI rose 0.5%, and the Hang Seng Technology Index rose 1.23%.
As of the noon close, Hong Kong stocks rose 704 stocks, fell 919 stocks, and closed flat at 1244 stocks.
In terms of sectors, most of the large technology stocks rose during the session. Meituan rose by nearly 5%, JD.com rose by more than 3%, Bilibili rose by more than 1%; Baidu fell by more than 1%, and NetEase fell by nearly 1%.
Infrastructure stocks rose, Conch Cement rose more than 6%, China National Building Materials rose more than 5%, China State Construction International rose more than 4%, and China Railway Group rose more than 1%.
Most oil stocks rose, with CNOOC up more than 2 percent and PetroChina up 0.54 percent.
Most of the coal stocks rose, Yancoal Australia rose 8%, Yitai Coal rose more than 2%; Mongolia Coking Coal and Yankuang Energy rose during the session.
Some auto stocks fell, Great Wall Motors fell more than 2%, BYD shares fell more than 1%; Ideal Auto and Geely Auto rose during the session.
Most of the pharmaceutical stocks fell , with Pioneer Pharmaceuticals down more than 9%, Fosun Pharmaceuticals down more than 8%, and Asymchem and Innovent also fell.
Some mainland property stocks and property management stocks fell, R&F Properties fell more than 4%, Sun Hung Kai Properties fell more than 1%; Country Garden Services fell more than 1%, and Sunac Services fell.
In terms of individual stocks, $Meituan-W(03690.HK)$ rose nearly 5%. The agency said that it reiterated its “positive” rating on China’s Internet industry, and preferred Tencent and Meituan.
$JD.com-SW(09618.HK)$ rose by more than 3%. Yesterday, JD.com rose by more than 5%, which is optimistic about the brokerage institutions.
$ Ganfeng Lithium (01772.HK) rose more than 8%. Xiaomo published a research report saying that it maintained the “overweight” rating of Ganfeng Lithium, and gave a target price of HK$180.
Chuangmengtiandi (01119.HK) rose over 23%, and plans to repurchase shares of no more than HK$200 million. In addition, the CEO of Chuangmengtiandi responded to yesterday’s plunge: everything is normal and will continue to increase.
Fosun Pharma (02196.HK) fell more than 8%. Fosun Pharma announced that the company achieved operating income of 10.382 billion yuan in the first quarter of 2022, a year-on-year increase of 28.87%; net profit attributable to the parent was 463 million yuan, a year-on-year decrease of 45.41% .
$ Jinxin Reproductive (01951.HK) $ fell more than 6%, and continued to bottom out today, setting a new low in the past 30 days. In addition, Credit Suisse released a research report stating that the target price of Jinxin Reproductive dropped from HK$10 to HK$9.4.
Half-day turnover TOP20
This article is reprinted from: https://news.futunn.com/post/14922770?src=3&report_type=market&report_id=204158&futusource=news_headline_list
This site is for inclusion only, and the copyright belongs to the original author.